Terms: = Lymphoma AND STAT6, D12S1644, 6778, ENSG00000166888, IL-4-STAT, P42226, STAT6B, STAT6C
172 results:
1. stat6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironment.
Benoit A; Abraham MJ; Li S; Kim J; Estrada-Tejedor R; Bakadlag R; Subramaniam N; Makhani K; Guilbert C; Tu R; Salaciak M; Klein KO; Coyle KM; Hilton LK; Santiago R; Dmitrienko S; Assouline S; Morin RD; Del Rincon SV; Johnson NA; Mann KK
Int J Hematol; 2024 Mar; 119(3):275-290. PubMed ID: 38285120
[TBL] [Abstract] [Full Text] [Related]
2. Human germline gain-of-function in stat6: from severe allergic disease to lymphoma and beyond.
;
Trends Immunol; 2024 Feb; 45(2):138-153. PubMed ID: 38238227
[TBL] [Abstract] [Full Text] [Related]
3. [CD23 positive, BCL2 rearrangement-negative germinal centre lymphomas].
Menter T; Quintanilla-Martinez L
Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):160-163. PubMed ID: 37932478
[TBL] [Abstract] [Full Text] [Related]
4. Surgical removal of an unusual huge solitary fibrous tumor in the mediastinum: a case report.
Mardani P; Nekooeian M; Zangeneh S; Kamran H; Shahriarirad R; Anbardar MH; Amirian A; Vafabin M
J Cardiothorac Surg; 2023 Sep; 18(1):262. PubMed ID: 37742027
[TBL] [Abstract] [Full Text] [Related]
5. Metastasis of solitary fibrous tumor to the parotid gland diagnosed on aspiration cytology supplemented with immunocytochemistry.
Kerkar A; Kundu R; Bhujade H; Singh H; Dey P
Diagn Cytopathol; 2023 Dec; 51(12):E345-E350. PubMed ID: 37675766
[TBL] [Abstract] [Full Text] [Related]
6. Higher 13-Gene-Estimated TMB Detected from Plasma ctDNA is Associated with Worse Outcome for T-Cell lymphoma Patients.
Chen C; Huang L; Chen Z; Ou Q; Liu S; Jiang X; Chen F; Wei X; Guo H; Shao Y; Zeng C; Li Y; Li W
Adv Biol (Weinh); 2023 Dec; 7(12):e2300042. PubMed ID: 37658484
[TBL] [Abstract] [Full Text] [Related]
7. Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms.
Kalmbach S; Grau M; Zapukhlyak M; Leich E; Jurinovic V; Hoster E; Staiger AM; Kurz KS; Weigert O; Gaitzsch E; Passerini V; Engelhard M; Herfarth K; Beiske K; Micci F; Möller P; Bernd HW; Feller AC; Klapper W; Stein H; Hansmann ML; Hartmann S; Dreyling M; Holte H; Lenz G; Rosenwald A; Ott G; Horn H;
Leukemia; 2023 Oct; 37(10):2058-2065. PubMed ID: 37563306
[TBL] [Abstract] [Full Text] [Related]
8. The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomas.
Salaverria I; Weigert O; Quintanilla-Martinez L
Blood Adv; 2023 Sep; 7(18):5258-5271. PubMed ID: 37561599
[TBL] [Abstract] [Full Text] [Related]
9. Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303.
Russler-Germain DA; Krysiak K; Ramirez C; Mosior M; Watkins MP; Gomez F; Skidmore ZL; Trani L; Gao F; Geyer S; Cashen AF; Mehta-Shah N; Kahl BS; Bartlett NL; Alderuccio JP; Lossos IS; Ondrejka SL; Hsi ED; Martin P; Leonard JP; Griffith M; Griffith OL; Fehniger TA
Blood Adv; 2023 Sep; 7(18):5524-5539. PubMed ID: 37493986
[TBL] [Abstract] [Full Text] [Related]
10. Desmoid-type fibromatosis of the mesentery: a clinicopatho-logical and genetic analysis of 9 cases.
Wang Q; Zhang L; Weng S; Zhou J; Gan M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 52(3):379-385. PubMed ID: 37476949
[TBL] [Abstract] [Full Text] [Related]
11. Autosomal Dominant stat6 Gain of Function Causes Severe Atopy Associated with lymphoma.
Minskaia E; Maimaris J; Jenkins P; Albuquerque AS; Hong Y; Eleftheriou D; Gilmour KC; Grace R; Moreira F; Grimbacher B; ; Morris EC; Burns SO
J Clin Immunol; 2023 Oct; 43(7):1611-1622. PubMed ID: 37316763
[TBL] [Abstract] [Full Text] [Related]
12. Diagnostic Utility of stat6 and pstat6 Immunohistochemistry for Distinguishing Classic Hodgkin lymphoma and Peripheral T-Cell lymphoma With Hodgkin and Reed-Sternberg-like Cells.
Satou A; Takahara T; Yamashita D; Seki M; Kato S; Tanioka F; Tsuyuki T; Wada E; Sakurai K; Karube K; Tsuzuki T; Nakamura S
Am J Surg Pathol; 2023 Aug; 47(8):897-906. PubMed ID: 37248961
[TBL] [Abstract] [Full Text] [Related]
13. Progression of Hodgkin lymphoma and plasma cell neoplasms: Report from the 2021 SH/EAHP Workshop.
Nejati R; Amador C; Czader M; Thacker E; Thakkar D; Dave SS; Dogan A; Duffield A; Goodlad JR; Ott G; Wasik MA; Xiao W; Cook JR
Am J Clin Pathol; 2023 Jun; 159(6):598-613. PubMed ID: 37085150
[TBL] [Abstract] [Full Text] [Related]
14. Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.
Shen R; Fu D; Dong L; Zhang MC; Shi Q; Shi ZY; Cheng S; Wang L; Xu PP; Zhao WL
Signal Transduct Target Ther; 2023 Apr; 8(1):145. PubMed ID: 37032379
[TBL] [Abstract] [Full Text] [Related]
15. Combined Reverse-Transcriptase Multiplex Ligation-Dependent Probe Amplification and Next-Generation Sequencing Analyses to Assign Unclassified BCL2
Sesboue C; Galtier J; Jeanneau M; Chauvel A; Laharanne E; Amintas S; Merlio JP; Bouabdallah K; Gros FX; de Leval L; Gros A; Parrens M
Mod Pathol; 2023 Feb; 36(2):100043. PubMed ID: 36853790
[TBL] [Abstract] [Full Text] [Related]
16. Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study.
Michot JM; Quivoron C; Sarkozy C; Danu A; Lazarovici J; Saleh K; El-Dakdouki Y; Goldschmidt V; Bigenwald C; Dragani M; Bahleda R; Baldini C; Arfi-Rouche J; Martin-Romano P; Tselikas L; Gazzah A; Hollebecque A; Lacroix L; Ghez D; Vergé V; Marzac C; Cotteret S; Rahali W; Soria JC; Massard C; Bernard OA; Dartigues P; Camara-Clayette V; Ribrag V
Am J Hematol; 2023 Apr; 98(4):645-657. PubMed ID: 36606708
[TBL] [Abstract] [Full Text] [Related]
17. JAK-STAT signalling shapes the NF-κB response in CLL towards venetoclax sensitivity or resistance via Bcl-XL.
Haselager MV; Thijssen R; Bax D; Both D; De Boer F; Mackay S; Dubois J; Mellink C; Kater AP; Eldering E
Mol Oncol; 2023 Jun; 17(6):1112-1128. PubMed ID: 36550750
[TBL] [Abstract] [Full Text] [Related]
18. ALK TKI therapy in patients with ALK-positive non-small cell lung cancer and brain metastases: A review of the literature and local experiences.
Cicin I; Martin C; Haddad CK; Kim SW; Smolin A; Abdillah A; Yang X
Crit Rev Oncol Hematol; 2022 Dec; 180():103847. PubMed ID: 36257531
[TBL] [Abstract] [Full Text] [Related]
19. JAK: Not Just Another Kinase.
Agashe RP; Lippman SM; Kurzrock R
Mol Cancer Ther; 2022 Dec; 21(12):1757-1764. PubMed ID: 36252553
[TBL] [Abstract] [Full Text] [Related]
20. Transformation of FL into DLBCL with a PMBL gene expression signature.
Loveday T; Duns G; Rimsza LM; Rech KL; Cook JR; Robetorye RS; Rosenthal AC; Ramsower CA; Yip TK; McKinney CL; Swerdlow SH; Bhavsar S; Steidl C; Gibson SE
Blood Adv; 2023 Mar; 7(6):893-899. PubMed ID: 36240289
[TBL] [Abstract] [Full Text] [Related]
[Next]